Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -82.84% is 33% above its 4-year average of -122.99%, near the high end of its 4-year range (-250.21%–-18.86%).
As of the fiscal period ended Tuesday, June 30, 2026. 8.84% below its 12-month average of -76.11%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -82.84%.
RETURN ON INVESTED CAPITAL (ROIC)
-82.84%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-76.11%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-136.76%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-8.84%
CURRENT VS 3Y AVG
+39.43%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-25.42%
median of 377 covered companies
CURRENT VS SECTOR MEDIAN
-225.87%
vs the sector median at left
Cardio Diagnostics Holdings, Inc.
Market Cap
$6.10M
Return on Invested Capital (ROIC)
-82.84%
TTM Avg
-76.11%
3Y Avg
-136.76%
5Y Avg
N/A
Market Cap
$6.10M
Return on Invested Capital (ROIC)
-209.05%
TTM Avg
-147.42%
3Y Avg
-107.09%
5Y Avg
-98.13%
Market Cap
$6.09M
Return on Invested Capital (ROIC)
-0.32%
TTM Avg
-32.77%
3Y Avg
-50.72%
5Y Avg
-41.90%
Market Cap
$6.03M
Return on Invested Capital (ROIC)
-84.15%
TTM Avg
-84.15%
3Y Avg
-84.15%
5Y Avg
-84.15%
Market Cap
$6.34M
Return on Invested Capital (ROIC)
-117.93%
TTM Avg
-116.75%
3Y Avg
-95.39%
5Y Avg
-83.55%
Market Cap
$6.44M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-251.59%
3Y Avg
-2172.61%
5Y Avg
-1769.42%
Market Cap
$5.63M
Return on Invested Capital (ROIC)
-94.08%
TTM Avg
-1223.16%
3Y Avg
-731.00%
5Y Avg
-532.24%
Market Cap
$6.72M
Return on Invested Capital (ROIC)
-90.17%
TTM Avg
-79.44%
3Y Avg
-64.42%
5Y Avg
-71.54%
Market Cap
$6.74M
Return on Invested Capital (ROIC)
-57.11%
TTM Avg
-311.64%
3Y Avg
-524.77%
5Y Avg
-524.77%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | $6.10M | -82.84% | -76.11% | -136.76% | N/A |
| Femasys Inc. (FEMY)vs › | $6.10M | -209.05% | -147.42% | -107.09% | -98.13% |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.09M | -0.32% | -32.77% | -50.72% | -41.90% |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $6.03M | -84.15% | -84.15% | -84.15% | -84.15% |
| Biomerica, Inc. (BMRA)vs › | $6.34M | -117.93% | -116.75% | -95.39% | -83.55% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.44M | N/A | -251.59% | -2172.61% | -1769.42% |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | -94.08% | -1223.16% | -731.00% | -532.24% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.72M | -90.17% | -79.44% | -64.42% | -71.54% |
| Aclarion, Inc. (ACON)vs › | $6.74M | -57.11% | -311.64% | -524.77% | -524.77% |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.76M | -107.99% | -407.39% | -445.97% | -342.27% |
ROIC
-82.8%
ROE
-87.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -82.84% |
| 2026-03-31 | -70.35% |
| 2025-12-31 | -87.25% |
| 2025-09-30 | -77.91% |
| 2025-06-30 | -62.18% |
| 2025-03-31 | -49.72% |
| 2024-12-31 | -81.30% |
| 2024-09-30 | -201.10% |
| 2024-06-30 | -226.88% |
| 2024-03-31 | -250.21% |
| 2023-12-31 | -181.28% |
| 2023-09-30 | -203.21% |
| 2023-06-30 | -203.60% |
| 2023-03-31 | -161.06% |
| 2022-12-31 | -105.74% |
| 2022-09-30 | -29.15% |
| 2022-06-30 | -18.86% |
| 2022-03-31 | -146.29% |
| 2021-12-31 | -97.92% |
